Osteoporosis

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

USPSTF Updates Osteoporosis Screening Recommendations for Fracture Prevention

All women 65, high-risk postmenopausal women 65 should undergo bone measurement testing.

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

Romosozumab Decreases Fracture Risk in Women With Osteoporosis Taking Alendronate

By

In postmenopausal women at high risk for fracture, treatment with romosozumab for 12 months, followed by alendronate, was associated with significantly fewer hip fractures than treatment with alendronate alone.

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Femoral Neck Bone Loss in Males Protected by High Dietary Fiber

Higher dietary fiber and fruit fiber is protective against bone loss at the femoral neck in men.

Vertebral Fracture Assessment vs Conventional Spine Radiography

Vertebral Fracture Assessment vs Conventional Spine Radiography

By

The use of vertebral fracture assessment has shown adequate performance for the detection of vertebral fractures.

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

Zoledronate Shows Prolonged Antiresorptive Activity in Postmenopausal Women With Osteopenia

By

Prolonged antiresorptive activity of ≥3 years has been associated with single zoledronate doses between 1 and 5 mg in postmenopausal women with osteopenia.

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

Incidence of New Fractures Reduced With Abaloparatide Followed by Alendronate

By

Tymlos is approved to treat postmenopausal women with osteoporosis at high risk for fracture.

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Incident Radiographic Vertebral Fractures Associated with Back Pain in Older Men

Clinically undiagnossed radiographic VFs are linked to increased back pain symptoms.

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Osteoporotic Fractures, Diabetes Complications Similarly Affect QoL

Quality of life is similarly impacted by osteoporotic fractures and complications of diabetes.

BMD in Menopause Improved With OSA-Related Hypoxia

BMD in Menopause Improved With OSA-Related Hypoxia

By

The risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

Hypoxia in OSA Lowers Risk of Bone Health Decline in Menopausal Women

By

Risk of bone health decline in menopausal women is decreased by intermittent hypoxia in OSA.

Do Depression, Anxiety Affect BMD in Anorexia?

Do Depression, Anxiety Affect BMD in Anorexia?

By

Anxiety and depression are associated with low BMD in anorexia patients.

Relationship of BMD and Physical Activity in Class III Obesity

Relationship of BMD and Physical Activity in Class III Obesity

By

In people with class III obesity, variance in femoral neck BMD can be determined by time spent doing light physical activity.

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

Prediction of Fractures and CV Events With Serum Osteoprotegerin Levels

By

Following adjustment, fracture risk was highest among patients in the lowest osteoprotegerin levels.

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

No Association Between Opioid Intake and Patient Satisfaction After Ankle Fracture

By

To improve pain relief, surgeons should proactively address stress, distress, and ineffective coping strategies.

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

K-Postn May Be Predictor of Fx Risk in Postmenopausal Women Independent of BMD and FRAX

By

K-Postn may serve as a predictor of incident low-trauma fractures in postmenopausal women.

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow Fat May Determine Bone Metabolism After Roux-en-Y Gastric Bypass

Marrow fat may determine bone mass after Roux-en-Y gastric bypass.

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

Denosumab Discontinuation for Osteoporosis: What Are the Risks?

By

Discontinuing denosumab therapy in osteoporosis may increase the risk for vertebral fractures.

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

BMD Increased by Romosozumab in Women Transitioning From Bisphosphonates

By

Romosozumab could be a better option than teriparatide for patients at a high risk for fracture.

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal Women

By

Fracture risk is able to be predicted as long as 25 years by a single BMD and fracture history assessment.

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis Meds Increase BMD in Nonmetastatic Prostate Cancer

Osteoporosis medications are increasing BMD in men with nonmetastatic prostate cancer who are receiving ADT.

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

Hip, Spine BMD Decline Slowed By Deferred Antiretroviral Therapy

By

The clinical benefits of beginning ART early outweigh the decrease outcomes related to bone mineral density.

Osteoporosis Tx Romosozumab Continues License Application

Osteoporosis Tx Romosozumab Continues License Application

By

The FDA has published a Complete Response Letter in reply to the BLA for romosozumab.

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Review Addresses Optimal Care of Type 2 Diabetes and Osteoporosis

Scientific evidence should be considered in optimal management of coexisting T2D and osteoporosis.

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

Lower Risk for Hip Fracture With Alendronate Use Among Older Patients

By

Alendronate treatment was associated with a significantly lower risk for hip fracture among older patients.

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Osteoporosis

By

Approval was based on the results of the ACTIVE and ACTIVExtension trials.

Osteoporosis More Likely in Multiple Sclerosis

Osteoporosis More Likely in Multiple Sclerosis

By

Osteoporosis was more prevalent in patients with MS compared with matched controls.

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause

By

Bone mineral density was statistically different from baseline after 24 months.

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

HIV-Induced Osteoporosis Detected Via Bone Ultrasonography

By

Bone ultrasonography was able to detect tenofovir-induced bone loss in patients with HIV.

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

By

Case study of an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

Cadmium Exposure Through Diet Increases Risk of Osteoporosis

By

This study shows that populations exposed to more cadmium in their diet were at a disproportionately increased risk of developing osteoporosis.

Sign Up for Free e-newsletters